Published ahead of print on April 29, 2004, doi:10.1164/rccm.200401-094OC
Am. J. Respir. Crit. Care Med., Volume 170, Number 4, August 2004, 408-413
A more recent version of this article appeared on August 15, 2004
Submitted on January 23, 2004
Accepted on April 27, 2004
Association of Chronic Obstructive Pulmonary Disease Severity and Pneumocystis Colonization
Alison Morris1*, Frank C Sciurba2, Irina P Lebedeva3, Andrew Githaiga2, W. Mark Elliott4, James C Hogg4, Laurence Huang5, and Karen A Norris3
1 Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Southern California, Los Angeles, CA, USA; Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, USA,
2 Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, USA,
3 Department of Immunology, University of Pittsburgh, Pittsburgh, PA, USA,
4 McDonald Research Laboratories, University of British Columbia, Vancouver, BC, Canada,
5 Department of Medicine, University of California, San Francisco General Hospital, San Francisco, CA, USA
* To whom correspondence should be addressed. E-mail: alison.morris{at}usc.edu.
Factors modulating the variable progression of chronic obstructive pulmonary disease (COPD) are largely unknown, but infectious agents may play a role. Because Pneumocystis has previously been shown to induce a CD8+ lymphocyte- and neutrophil-predominant response similar to that in COPD, we explored the association of the organism with accelerated disease progression. We examined Pneumocystis colonization rates in lung tissue obtained during lung resection or transplantation in smokers with a range of airway obstruction severity and in a control group with lung diseases other than COPD. Using nested polymerase chain reaction, Pneumocystis colonization was detected in 36.7% of patients with very severe COPD (Global Health Initiative on Obstructive Lung Disease [GOLD] stage IV) compared to 5.3% of smokers with normal lung function or less severe COPD (stages 0, I, II, and III)(p=0.004) and to 9.1% of controls (p=0.007). Colonized subjects exhibited more severe airway obstruction (median FEV1=21% predicted vs. 62% in non-colonized, p=0.006). GOLD IV was the strongest predictor of Pneumocystis colonization (odds ratio=7.3, 95% confidence interval=2.4-22.4, p<0.001) and was independent of smoking history. We conclude that there is a strong association between Pneumocystis colonization and severity of airflow obstruction in smokers, suggesting a possible pathogenic link with COPD progression.
Key words: Pneumocystis jiroveci, colonization, chronic obstructive pulmonary disease, emphysema, epidemiology
This article has been cited by other articles:

|
 |

|
 |
 
A. Morris, T. Alexander, S. Radhi, L. Lucht, F. C. Sciurba, J. K. Kolls, R. Srivastava, C. Steele, and K. A. Norris
Airway Obstruction Is Increased in Pneumocystis-Colonized Human Immunodeficiency Virus-Infected Outpatients
J. Clin. Microbiol.,
November 1, 2009;
47(11):
3773 - 3776.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sethi, P. Mallia, and S. L. Johnston
New Paradigms in the Pathogenesis of Chronic Obstructive Pulmonary Disease II
Proceedings of the ATS,
September 15, 2009;
6(6):
532 - 534.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Kovacs and H. Masur
Evolving Health Effects of Pneumocystis: One Hundred Years of Progress in Diagnosis and Treatment
JAMA,
June 24, 2009;
301(24):
2578 - 2585.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Beck and M. T. Cushion
Pneumocystis Workshop: 10th Anniversary Summary
Eukaryot. Cell,
April 1, 2009;
8(4):
446 - 460.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. T. Cushion, M. S. Collins, and M. J. Linke
Biofilm Formation by Pneumocystis spp.
Eukaryot. Cell,
February 1, 2009;
8(2):
197 - 206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sethi and T. F. Murphy
Infection in the Pathogenesis and Course of Chronic Obstructive Pulmonary Disease
N. Engl. J. Med.,
November 27, 2008;
359(22):
2355 - 2365.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I Petrache, K Diab, K S Knox, H L Twigg III, R S Stephens, S Flores, and R M Tuder
HIV associated pulmonary emphysema: a review of the literature and inquiry into its mechanism
Thorax,
May 1, 2008;
63(5):
463 - 469.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Huang, A. Morris, A. H. Limper, J. M. Beck, and on behalf of the ATS Pneumocystis Workshop Partici
An Official ATS Workshop Summary: Recent Advances and Future Directions in Pneumocystis Pneumonia (PCP)
Proceedings of the ATS,
November 1, 2006;
3(8):
655 - 664.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Crothers, A. A. Butt, C. L. Gibert, M. C. Rodriguez-Barradas, S. Crystal, A. C. Justice, and for the Veterans Aging Cohort 5 Project Team
Increased COPD Among HIV-Positive Compared to HIV-Negative Veterans.
Chest,
November 1, 2006;
130(5):
1326 - 1333.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Carmona, R. Vassallo, Z. Vuk-Pavlovic, J. E. Standing, T. J. Kottom, and A. H. Limper
Pneumocystis Cell Wall beta-Glucans Induce Dendritic Cell Costimulatory Molecule Expression and Inflammatory Activation through a Fas-Fas Ligand Mechanism
J. Immunol.,
July 1, 2006;
177(1):
459 - 467.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J F Donohue
Ageing, smoking and oxidative stress.
Thorax,
June 1, 2006;
61(6):
461 - 462.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sethi, J. Maloney, L. Grove, C. Wrona, and C. S. Berenson
Airway Inflammation and Bronchial Bacterial Colonization in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
May 1, 2006;
173(9):
991 - 998.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Sullivan, P. L. Simonian, M. T. Falta, J. D. Mitchell, G. P. Cosgrove, K. K. Brown, B. L. Kotzin, N. F. Voelkel, and A. P. Fontenot
Oligoclonal CD4+ T Cells in the Lungs of Patients with Severe Emphysema
Am. J. Respir. Crit. Care Med.,
September 1, 2005;
172(5):
590 - 596.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. N. Meissner, S. Swain, M. Tighe, A. Harmsen, and A. Harmsen
Role of Type I IFNs in Pulmonary Complications of Pneumocystis murina Infection
J. Immunol.,
May 1, 2005;
174(9):
5462 - 5471.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Fabbri, S. P. Peters, I. Pavord, S. E. Wenzel, S. C. Lazarus, W. MacNee, F. Lemaire, and E. Abraham
Allergic Rhinitis, Asthma, Airway Biology, and Chronic Obstructive Pulmonary Disease in AJRCCM in 2004
Am. J. Respir. Crit. Care Med.,
April 1, 2005;
171(7):
686 - 698.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Kim, G. J. Criner, H. Y. Abdallah, J. P. Gaughan, S. Furukawa, and C. C. Solomides
Small Airway Morphometry and Improvement in Pulmonary Function after Lung Volume Reduction Surgery
Am. J. Respir. Crit. Care Med.,
January 1, 2005;
171(1):
40 - 47.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 American Thoracic Society
|
|
|